Location History:
- Cambridge, MA (US) (2012)
- Bulle, CH (2008 - 2016)
Company Filing History:
4 out of 1,386 
4 out of 1,210 
Years Active: 2008-2016
Title: The Innovative Contributions of Laurent Monney
Introduction
Laurent Monney is a notable inventor based in Bulle, Switzerland. He has made significant contributions to the field of immunology, particularly through his research on T-cell activation and antigen-presenting cells. With a total of four patents to his name, Monney's work has the potential to impact various medical conditions.
Latest Patents
Monney's latest patents focus on methods related to TIM-3, a Th1-specific cell surface molecule. These inventions provide compositions and methods that are useful for promoting or reducing T-cell trafficking to target tissues. Additionally, they include compositions and methods for promoting or inhibiting antigen-presenting cell (APC) activation. The discovery of functional characteristics of TIM-3, which is preferentially expressed on the surface of Th1 cells, is central to these inventions. The methods developed are applicable in treating disorders such as cancer, infectious diseases, allergies, asthma, and autoimmune diseases.
Career Highlights
Throughout his career, Laurent Monney has worked with prestigious institutions, including Brigham and Women's Hospital and Dana-Farber Cancer Institute. His research has contributed to a deeper understanding of immune responses and therapeutic strategies.
Collaborations
Monney has collaborated with esteemed colleagues in his field, including Vijay K. Kuchroo and Jason L. Gaglia. These partnerships have furthered his research and innovation in immunology.
Conclusion
Laurent Monney's work exemplifies the intersection of innovation and medical research. His patents and collaborations highlight his commitment to advancing the understanding of immune mechanisms and developing potential treatments for various diseases.